Waldemar Priebe
Plus aucun poste en cours
Profil
Waldemar Priebe is the founder of Reata Pharmaceuticals, Inc. (founded in 2002), Moleculin Biotech, Inc. (founded in 2015), and CNS Pharmaceuticals, Inc. (founded in 2017).
Anciens postes connus de Waldemar Priebe
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Founder | - |
| CNS PHARMACEUTICALS, INC. | Founder | - |
| REATA PHARMACEUTICALS, INC. | Founder | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
